Search alternatives:
large decrease » marked decrease (Expand Search), large increases (Expand Search), large degree (Expand Search)
c larger » _ larger (Expand Search), c large (Expand Search), _ large (Expand Search)
i large » _ large (Expand Search), a large (Expand Search), via large (Expand Search)
ct also » can also (Expand Search)
b large » _ large (Expand Search), a large (Expand Search), _ larger (Expand Search)
large decrease » marked decrease (Expand Search), large increases (Expand Search), large degree (Expand Search)
c larger » _ larger (Expand Search), c large (Expand Search), _ large (Expand Search)
i large » _ large (Expand Search), a large (Expand Search), via large (Expand Search)
ct also » can also (Expand Search)
b large » _ large (Expand Search), a large (Expand Search), _ larger (Expand Search)
-
161
-
162
Table4_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX
Published 2022“…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …”
-
163
Table3_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX
Published 2022“…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …”
-
164
Table6_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX
Published 2022“…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …”
-
165
Table2_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX
Published 2022“…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …”
-
166
Table5_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX
Published 2022“…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …”
-
167
-
168
-
169
-
170
Inactivation of <i>ICL1</i> bypasses the effects of <i>MLS1</i> inactivation.
Published 2024Subjects: -
171
-
172
-
173
-
174
-
175
-
176
-
177
-
178
Antibody and antigen responses by baseline anti-spike neutralizing response assay positivity.
Published 2025Subjects: -
179
-
180